Should all adjunctive corticosteroid therapy be avoided in the management of hemodynamically stabile Staphylococcus aureus bacteremia?

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Erik ForsblomAsko Järvinen

Abstract

The purpose of this study was to examine the prognostic impact of corticosteroids in hemodynamically stabile Staphylococcus aureus bacteremia (SAB). There were 361 hemodynamically stabile methicillin-sensitive SAB patients with prospective follow-up and grouping according to time-point, dose and indication for corticosteroid therapy. To enable analyses without external interfering corticosteroid therapy all patients with corticosteroid therapy equivalent to prednisone >10 mg/day for ≥1 month prior to positive blood culture results were excluded. Twenty-five percent (92) of patients received corticosteroid therapy of which 11 % (40) had therapy initiated within 1 week (early initiation) and 9 % (31) had therapy initiated 2-4 weeks after (delayed initiation) positive blood culture. Twenty-one patients (6 %) had corticosteroid initiated after 4 weeks and were not included in the analyses. A total of 55 % (51/92) received a weekly prednisone dose >100 mg. Patients with early initiated corticosteroid therapy had higher mortality compared to patients treated without corticosteroid therapy at 28 days (20 % vs. 7 %) (OR, 3.11; 95%CI, 1.27-7.65; p < 0.05) and at 90 days (30 % vs. 10 %) (OR, 4.01; 95%CI, 1.82-8.81; p < 0.001). Considerin...Continue Reading

References

Sep 1, 1976·Annals of Surgery·W Schumer
Jul 1, 1995·Critical Care Medicine·R Lefering, E A Neugebauer
Feb 25, 1998·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L O ConternoA Castelo
Apr 29, 1998·Critical Care Medicine·P E BollaertA Larcan
Nov 14, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J M Mylotte, A Tayara
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Djillali AnnaneEric Bellissant
Dec 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E CosgroveYehuda Carmeli
Apr 12, 2003·Critical Care Medicine·Mitchell M LevyUNKNOWN SCCM/ESICM/ACCP/ATS/SIS
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas P LodiseMichael J Rybak
Sep 25, 2003·Archives of Internal Medicine·Vance G FowlerEugene Z Oddone
Aug 4, 2004·BMJ : British Medical Journal·Djillali AnnaneYizhak Kupfer
Sep 6, 2005·Scandinavian Journal of Infectious Diseases·Yardena Siegman-IgraMichael Giladi
Mar 10, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C KaechU Fluckiger
Nov 7, 2007·Antimicrobial Agents and Chemotherapy·Sung-Han KimKang-Won Choe
Sep 2, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Heidi AmmerlaanUNKNOWN European Practices of Infections with Staphylococcus aureus (SEPIA) Study Group
May 25, 2010·The American Journal of Medicine·Hitoshi HondaDavid K Warren
Jul 16, 2010·Critical Care : the Official Journal of the Critical Care Forum·John L MoranAndrew D Bersten
Nov 17, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M NagaoS Ichiyama
Oct 11, 2012·Infectious Diseases in Clinical Practice : IDCP·Alexa A PragmanGregory A Filice
Oct 23, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E ForsblomA Järvinen
Jan 23, 2015·Arthritis Research & Therapy·Marlies C van der GoesJohannes W Bijlsma

❮ Previous
Next ❯

Citations

Apr 12, 2017·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Jin-Xin ZhengZhi-Jian Yu
Apr 30, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johannes CampSiegbert Rieg

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.